ESMO Advanced Course on Deep Dive in CDK4-6 Inhibitors Data in Breast Cancer 2023: Dubai

Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning Objectives

• Understanding the function and biology of CDK4-6 in malignant breast cancer cells
• Information and in-depth discussion on the state of the art and emerging therapeutic strategies integrating CDK4-6 inhibition in breast cancer, both in the metastatic setting
• Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of CDK4-6 inhibition
• Providing an outlook of potential integration of CDK 4-6 inhibitors in the adjuvant setting
• Discussing clinical cancer cases to integrate use of CDK 4-6 inhibitors in clinical practice